SINGAPORE, July 1, 2026 /PRNewswire/ — SuperX AI Technology Limited (NASDAQ:SUPX), a NASDAQ-listed full-stack AI infrastructure solutions provider, announced that SuperX Optical Communications Pte. Ltd., a Singapore joint venture jointly established by SuperX, a Singapore subsidiary of Suzhou TFC Optical Communication Co., Ltd. and APEX VERVE LIMITED, has completed business registration and full capital contribution, marking the official launch of the joint venture agreement.

The joint venture entity has a registered capital of SGD 2 million. SuperX holds a 45% equity stake, TFC’s Singapore subsidiary holds 35%, and APEX VERVE LIMITED holds the remaining 20%. The company adopts a multi-party collaborative board governance structure, with each party appointing directors to jointly participate in R&D, operation and market planning. Leveraging complementary resources in AI server, optical device manufacturing and regional channel networks, the joint venture’s business covers all global markets excluding Chinese Mainland, Hong Kong and Macao. Enabled by integrated technologies from all parties, the joint venture has rolled out two self-developed silicon-photonics optical modules: XOC 800G OSFP and XOC 1.6T OSFP. Both adopt silicon-photonics integration solution based on 1310nm CW laser light source, supporting a transmission distance of up to 500 meters over single-mode fiber, complying with OSFP MSA Rev.5.0 and CMIS Rev.5.1management interface standards. Tailored for high-speed computing scenarios of 800G and 1.6T respectively, they support mainstream Ethernet and InfiniBand protocols to meet the high-speed interconnection demands of AI supercomputing clusters.

Overseas AI infrastructure is undergoing rapid expansion. Overseas investment in AI infrastructure is projected to exceed USD 470 billion in 2026, driving sustained surging demand for 800G and 1.6T high-speed optical interconnects. SuperX has independently developed AI servers with liquid cooling, HVDC power supply and modular machine solutions, serving AI projects across Europe, the U.S., the Middle East and Southeast Asia. However, externally sourced optical components have created bottlenecks in adaptation, delivery and cost, restricting the company’s capacity to deliver integrated turnkey solutions.

The joint venture platform will introduce TFC’s mature mass-production technologies for high-speed optical devices, silicon photonics and Co-packaged Optics (CPO), developing customized optical interconnect products for SuperX’s AI server and launching one-stop computing cluster solutions. The self-developed 800G and 1.6T silicon-photonics transceivers will feature deep compatibility with NVIDIA’s new-generation CPO, creating differentiated market competitiveness.

Distinct from the industry’s common pure external procurement model, this asset-light joint venture enables SuperX to lock in a stable supply chain of high-end optical interconnect products without building its own production lines, optimizing profit elasticity. The three parties will jointly advance customer testing and validation of the two optical transceivers, and deploy supporting facilities for multiple GW-scale computing centers in the Middle East and Southeast Asia.

SuperX’s management stated that this collaboration fills the critical gap in the company’s optical interconnect industrial chain and delivers technological commercialization of self-developed 800G/1.6T silicon-photonics products. The company is now fully capable of delivering complete end-to-end AI computing solutions to global clients, substantially lifting its comprehensive competitiveness in overseas markets and unlocking long-term performance growth potential.

About SuperX AI Technology Limited

SuperX AI Technology Limited is an AI infrastructure solutions provider, offering a comprehensive portfolio of proprietary hardware, advanced software, and end-to-end services for AI data centers. The Company’s services include advanced solution design and planning, cost-effective infrastructure product integration, and end-to-end operations and maintenance. Its core products include high-performance AI servers, 800 Volts Direct Current (800VDC) solutions, high-density liquid cooling solutions, as well as AI cloud and AI agents. Headquartered in Singapore, the Company serves institutional clients globally, including enterprises, research institutions, and cloud and edge computing deployments. For more information, please visit www.superx.sg 

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of U.S. federal securities laws. All forward-looking statements are based on the Company’s current expectations and projections regarding future market conditions, business operations and financial performance, and are identified by words including “expects,” “anticipates,” “plans,” “potential,” “may,” “will” and comparable terminology.

Numerous risks and uncertainties could cause actual results to differ materially from any forward-looking statements contained herein, including rapid technological evolution, shifting global market requirements, intensifying industry competition, changes to U.S., Singapore and Chinese export control, trade and sanctions laws, continued maintenance of NVIDIA Partner Network credentials for the Company’s affiliated entities, operational risks associated with business activities in China, and reliance on indirect subsidiary partners such as Apex AI.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. SuperX undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Follow our social media:

• X: @SUPERX_AI_
• LinkedIn: SuperX AI
• Facebook: SuperX AI Technology Limited

“Taiwan, Never Sleeps” campaign inspires more than 225 travel industry professionals across Sydney, Melbourne and Auckland

SYDNEY, July 1, 2026 /PRNewswire/ — The Taiwan Tourism Administration (TTA) has concluded a three-city trade roadshow across Australia and New Zealand, engaging more than 225 travel industry professionals across Sydney, Melbourne and Auckland. Running from 17 to 25 June, the Taiwan Tourism Roadshows brought together airlines, hotels, travel agencies and cultural organisations to showcase the island’s diverse, year-round tourism offer.

Staged under the campaign theme “Taiwan, Never Sleeps,” the roadshows highlighted Taiwan’s around-the-clock appeal — from vibrant breakfast culture and morning markets to Michelin-recognised dining, legendary night market street food and a thriving urban nightlife scene. The series formed part of Taiwan Tourism Brand 3.0, “TAIWAN – Waves of Wonder,” reinforcing Taiwan’s positioning as a multi-layered, high-quality destination for travellers from the region.

Visitor Growth from Australia and New Zealand

Visitor numbers from both markets continued to grow strongly in 2025. Australia recorded 125,288 arrivals to Taiwan — an increase of 11.32% year-on-year — while leisure travel grew at an even faster pace, rising 16.63%. New Zealand contributed 18,242 arrivals, up 6.97%, with leisure travel climbing 10.4%.

Taiwan currently operates 21 direct flights per week to and from Australia and New Zealand, providing travellers with convenient access to the island. Research indicates that travellers from both markets place a high value on cultural experiences and culinary exploration, areas in which Taiwan continues to excel.

B2B Matchmaking and Trade Engagement

Each roadshow featured structured one-on-one business meeting sessions ahead of the main evening event, giving Australian and New Zealand product managers direct access to Taiwanese travel industry partners. Participants included leading online travel agencies (OTAs), independent and chain travel agencies, inbound and outbound tour operators, tourism associations and travel trade media.

Sessions focused on itinerary development, themed product design and channel partnerships — generating tangible commercial outcomes and broadening the distribution network for Taiwan tourism products across the region.

Cultural Highlights

Each event featured live performances and hands-on cultural activities designed to give trade attendees a genuine feel for Taiwan’s creative heritage. Performing group Mooz brought the island’s stories to life through the traditional Yueqin (moon lute), while celebrated paper artist Hung Hsin-Fu showcased Taiwan’s biodiversity through intricate ecological origami. Guests participated in a tile-painting workshop with SanHe Tile Kiln — a century-old heritage brand rooted in traditional Taiwanese architecture — and crafted their own floral-fabric sky lanterns as an introduction to Taiwan’s blessing traditions and everyday culture.

“The roadshow reinforced the strength of our partnerships across Australia and New Zealand and created meaningful new opportunities for product development and distribution. Taiwan’s combination of safety, accessibility, culinary depth and natural spectacle continues to resonate strongly with travellers from both markets, and we look forward to welcoming even more visitors in the year ahead.”

— Taiwan Tourism Administration

About Taiwan

Taiwan offers Australian and New Zealand travellers an exceptional blend of dramatic mountain scenery, Pacific coastline, world-class cycling, vibrant cities and a food culture recognised by Michelin and celebrated globally. With visa-free entry for Australian and New Zealand passport holders, direct air connectivity and a reputation for safety and hospitality, Taiwan is one of Asia’s most accessible and rewarding short-haul destinations.

For trip planning and travel inspiration, visit eng.taiwan.net.tw.

Leading Companies Present Science-Backed Solutions Addressing Antimicrobial Resistance, Digestive Health, and Wellness Through Advanced Probiotics and Clinical Botanicals

BANGKOK, July 1, 2026 /PRNewswire/ — As global healthcare confronts the urgent challenge of antimicrobial resistance, Vitafoods Asia 2026, the region’s premier nutraceutical trade show organised by Informa Markets, will showcase pioneering solutions that blend scientific rigour with natural innovation. Leading this charge are LiveSpo and Natural Remedies, two industry innovators presenting breakthrough technologies that address critical health burdens through advanced probiotics and clinical botanicals.

From the world’s first probiotic nasal spray to next-generation botanical ingredients delivering unprecedented efficacy at minimal doses, these companies demonstrate how evidence-based natural solutions can reduce antibiotic dependence while supporting digestive health, respiratory wellness, and immunity. Their innovations represent the convergence of traditional wisdom and modern science, offering effective, sustainable alternatives to conventional treatments for global populations facing pressing health challenges.

LiveSpo: Pioneering a Future Without Antibiotics

LiveSpo, a biotechnology leader specialising in spore-based probiotics, is introducing world-first innovations that could transform how healthcare approaches antibiotic usage. The company is the first and only manufacturer globally to successfully produce high-quality, multi-species spore probiotics in liquid form, enabling clinically validated products across multiple applications.

At the forefront of LiveSpo’s innovations is LiveSpo NAVAX, the world’s first probiotic nasal spray designed to support respiratory health. Clinical trials demonstrate that NAVAX shortens RSV infection symptoms by one day and influenza symptoms by one to two days while increasing treatment effectiveness by 10–60% compared with physiological saline. The formulation reduces pro-inflammatory cytokines up to 3.6-fold more effectively in RSV cases and shortens pneumonia symptom duration by one day with 20–90% improved treatment efficacy.

LiveSpo’s digestive health portfolio addresses the global burden of digestive disorders, which cause approximately 1.8 million deaths annually, with over 80% occurring in children under five years. LiveSpo Clausy, LiveSpo Colon, and LiveSpo Dia30 have been clinically shown to reduce antibiotic treatment duration by up to 25% when used alongside standard therapy and shorten persistent diarrhoea treatment by approximately three days. These formulations provide two-fold greater improvement in IBD-related symptom severity compared with control groups.

LiveSpo Kids specifically targets paediatric digestive wellness, demonstrating five-fold improvement in constipation management and eleven-fold enhancement in appetite compared to standard treatments. Clinical studies show the formulation increases weight by 0.3 kg per month in growing children while reducing pro-inflammatory cytokine IL-23 concentration nine-fold and increasing IgA ten-fold by day 28.

LiveSpo’s unique spore probiotic technology provides 24-month stability in zone 4B with no cold storage required, ensuring product quality regardless of shipping route—a critical advantage for global distribution.

“I always believe that the most important thing for a scientist is how their research is applied in real life, how it can benefit and serve the community,” said Dr. Nguyen Hoa Anh, Chairman and Founder of LiveSpo. “Every year, there are about 5 million deaths worldwide caused by antibiotic resistance, mostly among children under 5 years old. The World Health Organisation has repeatedly warned about the global issue of drug resistance, but until now, WHO has not provided an effective tool to replace antibiotics. In 2013, LiveSpo Pharma successfully researched and developed the technology for producing Liquid Form, Multi-strains, High Concentration Spore Probiotics, which have the potential to gradually replace antibiotics.”

He further added, “Vitafoods Asia provides the ideal platform for us to showcase our advanced spore probiotic technology to reputable partners across the region. As we pursue strategic regional expansion, this event allows us to connect with key industry players who share our vision of delivering innovative, science-backed probiotic solutions. We’re eager to demonstrate how our pioneering liquid spore probiotic technology can help partners address critical health challenges while supporting our mission toward a future without antibiotics”

Natural Remedies: Transforming Nature into Clinical Excellence

Natural Remedies – Human Health Care brings decades of botanical expertise combined with cutting-edge science to Vitafoods Asia 2026. The company is showcasing its portfolio of clinically researched, standardised herbal ingredients designed for the global nutraceutical market.

The spotlight innovation is Ashwa.30™, a next-generation Ashwagandha ingredient powered by proprietary B.O.T™ (Bioactive Optimisation Technology). This breakthrough delivers benefits for energy, endurance, longevity, and stress management at just 30 mg per day, redefining efficacy in low-dose botanical supplementation.

Natural Remedies’ comprehensive portfolio of clinically validated ingredients addresses multiple health categories. Holixer® is an award-winning ingredient clinically shown to provide better sleep experience, while BacoMind® enhances memory, focus, and recall. Gutgard® offers daily support for optimal digestive health, and Turmacin® provides water-soluble turmeric for superior joint health. The company’s AP-Bio® / Kalmcold® offers trusted immune support solutions.

All ingredients combine traditional wisdom with rigorous scientific validation, featuring clinically proven efficacy, standardised bioactive profiles, low effective dosages, and global regulatory readiness. Products are registered with TGA, ANVISA, and KFDA, and comply with USA and EU standards, ensuring premium quality and trust worldwide. The company maintains ISO-certified R&D facilities and conducts rigorous clinical trials while practising responsible sourcing, biodiversity conservation, and greener energy solutions.

“The future of wellness lies in botanicals that combine traditional wisdom with modern scientific validation,” said Dr. Suresh, Chief Business Officer, Natural Remedies. “Through innovations like B.O.T Technology, we are enabling the next generation of high-performance, science-backed botanical solutions.”

He further added, “As a global leader in science-backed botanical ingredients, we see Vitafoods Asia as an essential trade event for connecting with partners and industry leaders who are shaping the future of health and wellness. This year, we’re excited to showcase our latest innovations and demonstrate how clinically validated botanicals can empower brands to create truly differentiated, evidence-based products that meet evolving consumer demands for natural, effective health solutions.”

Both companies serve nutraceutical, dietary supplement, functional food, beverage, and pharmaceutical sectors, with particular strength in active longevity and healthy ageing, stress and sleep management, cognitive performance, digestive and metabolic health, sports nutrition, immune support, and respiratory wellness.

For more information about Vitafoods Asia 2026, visit www.vitafoodsasia.com

About Vitafoods Asia

Vitafoods Asia is the leading nutraceutical event in Asia, bringing together industry professionals from across the globe to explore the latest trends, innovations, and opportunities in the nutraceutical and functional food sectors.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com. 

For media inquiries, please contact:

Gautam Jatwani
Senior Marketing Manager
Gautam.jatwani@informa.com

HONG KONG, July 1, 2026 /PRNewswire/ — DL Holdings Group Limited (1709.HK) announced its annual results for the year ended 31 March 2026 on 30 June. During the period, the Group recorded a net profit of HK$367 million, representing a year-on-year increase of approximately 168%; revenue of approximately HK$324 million, up 71% year-on-year; and net assets of approximately HK$2.721 billion, up 187% year-on-year. Total assets reached HK$3.35 billion, up 160% year-on-year. At the same time, DL Holdings’ dividend plan for this period surpasses HK$160 million, comprising: HK$20 million in cash, HK$61 million in equity interests of DL Tower in the form of RWA, HK$39 million in fixed-income RWA linked to the ONE Carmel residential construction, and 40 million bonus shares.

Alongside this marked improvement in performance, the Group continued to advance its business restructuring and strategic upgrade, focusing on the development of financial services, family office, and digital finance segments, while continuing to strengthen its asset allocation and investment capabilities, driving the Group toward a new stage of diversified, platform-based, and innovation-driven development.

The Group has now established four core business segments working in synergy: first, traditional family office and asset management (DL Family Office, DL Asset Management); second, traditional securities brokerage and investment banking (DL Securities); third, digital assets and RWA (DL Digital Finance); and fourth, digital AI family office and investment finance community (NeuralFin and ARTi). 

On the proprietary investment side, the Group allocates capital around four core long-term assets, namely the top-tier ONE Carmel real estate project in California, USA; digital currency and digital gold; DL Tower; and private equity, private credit, and secondary market funds. Underpinned by this business matrix and asset base, the Group achieved a twofold leap in both revenue and profit during the reporting period, laying a solid foundation for the next stage of platform-based, innovation-driven growth.

Performance Highlights and Financial Results

During the period, the Group’s core businesses maintained steady growth, with revenue increasing from HK$190 million in the prior year to HK$324 million, driven primarily by its licensed financial services business and family office services business. Of this, revenue from licensed financial services was approximately HK$120 million, and revenue from family office services was approximately HK$57 million, both recording year-on-year growth and continuing to serve as the Group’s core revenue sources. Meanwhile, the Group’s gross profit rose to HK$268 million, up 93% year-on-year, underscoring the resilience of its businesses through economic cycles.

On profitability, the Group’s net profit for the year was HK$367 million, a significant increase from the prior year, driven primarily by fair value gains on financial assets at fair value through profit or loss, fair value gains on associates, and fair value gains on investment properties. Supported by these gains, together with a reduction in finance costs and a decline in administrative expenses, the Group’s profit performance improved substantially for the year, with overall profitability notably enhanced.

In terms of financial position, the Group held cash and cash equivalents of approximately HK$370 million at year-end, reflecting a sound liquidity position. At the same time, the Group’s asset base expanded significantly, with total assets notably higher than the prior year, primarily reflecting growth in financial assets, fair value investments, and assets related to business expansion. This demonstrates that the Group, while consolidating its traditional financial businesses, is also continuing to strengthen its capital operations and investment capabilities.

Building a Digital Finance Ecosystem Through Technology and Innovation, Empowering a Broader Base of Investors

During the reporting period, the Group continued to deepen its top-level digital finance strategy. Building on its established track record in cryptocurrency mining and digital asset investment, the Group simultaneously extended into the AI computing infrastructure sector, achieving coordinated development between digital assets and intelligent computing power. It secured core resources in North American data centers, GPU inference, and the conversion of crypto mining facilities, while expanding its channels for accessing overseas power supply and site resources, building a complete industry loop spanning crypto computing power, AI inference, and digital financial services. The Group is actively positioning its AI computing infrastructure as a new growth trajectory, further solidifying its “compute plus finance” tech-driven profile, and delivering on the digital finance strategy previously outlined in annual report.

Beyond its overseas infrastructure deployment, the Group also made parallel progress in its proprietary fintech businesses. NeuralFin (突触科技), in which the Group has invested, launched a suite of intelligent tools including AI-generated short-video research summaries, an AI wealth advisor, and Capital Radar, with the platform’s registered users surpassing 190,000. Rice Vault (米倉), the financial social app dedicated to the Chinese mainland market, has been rolled out across all channels on the App Store and major Android app stores, using a financial community as the vehicle to connect content discovery, AI-driven research, and asset trading into a single end-to-end pathway, making mass-market investment services more accessible. Less than two months after launch, the app’s users had already surpassed 40,000.

As product capabilities have matured, ARTi, the institutional-grade AI investment research platform for professional investors in which DL Holdings has invested, also reached an important development milestone, securing a US$1.5 million Pre-Series A investment from C Capital in June 2026 at a pre-money valuation of US$30 million. The platform is built on a proprietary multi-agent AI architecture, with a uniquely developed framework of 9 AI analysts × 9 investment masters × 9-layer data architecture for cross-validation, effectively addressing the pain point of financial hallucination common to general-purpose large language models. With its core strengths in fully traceable data and accumulable investment logic, the platform delivers a one-stop suite of institutional services spanning AI investment advisory and automated investment decision-making. Building on this technology, ARTi is accelerating its horizontal expansion into the prediction markets space, aiming to deliver forward-looking investment research products that cover macroeconomic events, policy trends, and asset price movements, thereby further enriching its AI-powered data services matrix.

Taken together, the Group has built a complete digital finance ecosystem spanning overseas AI computing infrastructure, institutional-grade professional investment research through ARTi, mass-market social wealth services through NeuralFin, and compliant virtual asset trading. The Group will continue to advance financial AI innovation within a compliant framework, broadening its digital finance growth curve. Looking ahead, the Group will use robust compliance as its foundation to drive more efficient synergy across its ecosystem’s business units in terms of data, products, and customers.

Committed to Long-Termism, Deepening Investment in Cross-Border High-End Real-World Assets

Beyond its digital finance initiatives in AI computing power, ARTi’s institutional AI research, and NeuralFin’s consumer wealth platform, the Group has simultaneously continued to build out its long-term, cross-border, high-end real-world asset holdings: ONE Carmel, an art-focused real estate project in California, USA, has officially entered Phase 4.0.

Around this project, the Group has further strengthened its overall positioning across global asset allocation, family lifestyle, and art and wellness. Spanning approximately 3.6 square kilometers, ONE Carmel blends European artistic traditions, Asian lifestyle aesthetics, and Silicon Valley’s AI innovation ecosystem. In partnership with leading European art institutions, the project has introduced a co-created Art Residence concept and is developing the ONE Plus Longevity and Wellness Center, building an integrated, low-profile luxury community that brings together humanities, technology, and health. Anchored by a dedicated foundation that sustains its cultural ecosystem, the project is positioned not as conventional real estate, but as a legacy asset carrying the family’s spirit forward.

ONE Carmel forms a deep synergy with the Group’s digital finance businesses: AI investment research and wealth tools such as ARTi and NeuralFin can provide clients with research and analysis on global real-world assets, while the project’s high-quality underlying real assets are also well suited to the Group’s RWA tokenization and cross-border family office allocation businesses. This year’s dividend already includes HK$40 million of fixed-income RWA linked to the ONE Carmel residential construction.

Looking to the future, DL Holdings stands at a pivotal juncture in its transformation from a “comprehensive traditional financial services provider” to a company “building a wealth ecosystem for the digital AI era.”  This twofold leap in net profit and asset scale is the reward for strategic discipline; the launch of its dividend policy is a sincere return of trust to its shareholders. And the deep convergence of digital finance with real-world assets, together with the two-way empowerment between AI technology and family office services, sketches out a clear growth trajectory for the Group’s next chapter.